Context Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -36 | -32 | -4 | |
EBITDA | -14,558 | -8,644 | -13,021 | -9,689 |
EBIT | -8,680 | -13,025 | -9,693 | |
Net Income | -14,558 | -8,680 | -13,025 | -9,693 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,038 | -11,466 | -8,942 | -6,578 |
Cash | 42,990 | 54,528 | 65,995 | 76,938 |
Basic Shares | 95,183 | 95,183 | 91,879 | 95,185 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -124 | -52 | -12 | -9 |
EBITDA | -36,107 | -26,714 | -23,952 | -14,871 |
EBIT | -36,123 | -26,725 | -23,964 | -14,881 |
Net Income | -36,123 | -26,725 | -23,964 | -14,835 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -26,419 | -29,314 | -21,047 | -14,086 |
Cash | 65,995 | 94,429 | 14,449 | 35,497 |
Basic Shares | 95,185 | 58,416 | 15,966 | 15,966 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.15 |
2026-03-31 | -$0.09 |
2025-12-31 | -$0.14 |
2025-09-30 | -$0.10 |